Autism clinical trials at UC Davis
2 research studies open to eligible people
Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
“Together, we can make a difference for children and teens with autism.”
open to eligible people ages 10-17
This is a multicenter, randomized, double-blind, placebo-controlled study in pediatric patients who are experiencing major depressive episodes (MDEs) associated with a primary diagnosis of bipolar I or bipolar II disorder as confirmed by Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL), according to criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM 5).
Sacramento, California and other locations
Early Start Denver Model in Community Programs Serving Young Autism
“Partnering for Autism: Learning More to improve Services”
open to eligible people ages 12 months and up
This study tests the effectiveness of the Early Start Denver Model (ESDM) in community agencies that serve young autistic children. The feasibility, usability and acceptability of the model will be explored. Understanding effectiveness of new evidence-based models will increase the quality of autism care available to more diverse children and families in more geographic locations.
Sacramento, California
Our lead scientists for Autism research studies include Aubyn C Stahmer, PhD.